Beckman Richard 4
4 · Adverum Biotechnologies, Inc. · Filed Feb 9, 2022
Insider Transaction Report
Form 4
Beckman Richard
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-07+485,000→ 485,000 totalExercise: $1.58Exp: 2032-02-06→ Common Stock (485,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of February 7, 2022 (the "Vesting Commencement Date"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.